AbbVie News - ABBV

Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX/DowJones/S&P)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
AbbVie Inc ABBV NYSE Common Stock
  Änderung Änderung % Aktuell Hoch Niedrig Handelsbeginn Handelsende Zeit
  0,39 0,52% 75,14 76,18 74,65 74,99 74,75 02:00:00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.10.201916:36DJNForm 8.3 - [Allergan plc]
16.10.201916:22DJNForm 8.3 - [Allergan plc]
16.10.201901:58DJNHealth-Care Stocks Get a Welcome Respite -- Update
15.10.201918:56DJNHealth-Care Stocks Get a Welcome Respite
15.10.201916:22DJNElizabeth Warren's Rise Is Battering Health-Care Stocks
15.10.201915:42DJNForm 8.3 - Allergan Plc
15.10.201914:29DJNElizabeth Warren's Rise Is Battering Health-Care Stocks
14.10.201915:11DJNForm 8.3 - Allergan Plc
11.10.201914:57DJNForm 8.3 - Allergan Plc
10.10.201918:41DJNReata Pharmaceuticals Shares Up 8% on Re-Acquiring..
10.10.201914:35DJNForm 8.3 - Allergan Plc
10.10.201913:49DJNReata Pharmaceuticals Reacquires Rights to Bardoxolne
09.10.201915:02DJNForm 8.3 - Allergan Plc
09.10.201908:01PRNUSAbbVie Announces New Data from its Dermatology Portfolio and..
08.10.201914:46DJNForm 8.3 - Allergan Plc
08.10.201914:30PRNUSAbbVie to Host Third-Quarter 2019 Earnings Conference Call
07.10.201916:40DJNForm 8.3 -Allergan Plc
04.10.201915:23DJNForm 8.3 - [Allergan plc]
03.10.201915:52DJNForm 8.3 - Allergan Plc
02.10.201915:20DJNForm 8.3 - Allergan Plc
01.10.201923:56EDGARStatement of Changes in Beneficial Ownership (4)
01.10.201923:53EDGARStatement of Changes in Beneficial Ownership (4)
01.10.201923:51EDGARStatement of Changes in Beneficial Ownership (4)
01.10.201923:49EDGARStatement of Changes in Beneficial Ownership (4)
01.10.201916:52DJNForm 8.3 - [Allergan Plc]
30.9.201915:26DJNForm 8.3 - [Allergan Plc]
30.9.201915:23DJNForm 8.3 - [AbbVie Inc.]
27.9.201923:38DJNFTC Requests for More Information From AbbVie-Allergan..
27.9.201922:16PRNUSAllergan and AbbVie Receive Second Request from Federal..
27.9.201922:15PRNUSAbbVie and Allergan Receive Second Request from Federal..
27.9.201915:36DJNForm 8.3 - [Allergan Inc.]
27.9.201902:00PRNUSAbbVie Receives FDA Approval of MAVYRET®..
26.9.201922:51EDGARCertification by the Exchange Approving Securities for..
26.9.201922:41EDGARSecurities Registration (section 12(b)) (8-a12b)
26.9.201922:07EDGARCurrent Report Filing (8-k)
26.9.201918:19DJNAbbVie Shares Rise After Upgrade From Citigroup
26.9.201916:34DJNForm 8.3 - Allergan Plc
25.9.201916:53DJNForm 8.3 - Allergan Plc
25.9.201915:00PRNCAVENCLEXTA®, a treatment for chronic lymphocytic leukemia..
24.9.201916:50DJNForm 8.3 - Allergan Plc
24.9.201914:45NNWGene Therapies with Potential to Conquer Tough-to-Tackle..
23.9.201922:25EDGARCurrent Report Filing (8-k)
23.9.201916:44DJNForm 8.3 - Allergan Plc
23.9.201909:01PRNUSAbbVie to Present New and Updated Data From 22 Abstracts,..
20.9.201917:41DJNForm 8.3 - [Allergan Plc]
19.9.201923:19EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
19.9.201916:57DJNForm 8.3 - Allergan Plc
18.9.201922:25EDGARStatement of Changes in Beneficial Ownership (4)
18.9.201916:35DJNForm 8.3 - Allergan Plc
17.9.201922:11EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20191018 01:09:42